register

ESG

New Leukaemia Foundation CEO steps up the fight for a blood cancer-free future

Health Industry Hub | January 29, 2021 |

The Leukaemia Foundation has launched into 2021 with renewed energy, experience and passion at the helm, as newly-appointed Chief Executive Officer Chris Tanti commences leading the organisation from Monday 1 February 2021.

An accomplished CEO in Australia and America, Mr Tanti began his career in social work and, for the past 25 years, has held national and international senior executive positions, including CEO of Australia’s National Disability Services and leading mental health organisation, Headspace.

Mr Tanti holds qualifications from La Trobe and Melbourne Universities, in addition to Harvard Business School, and has dedicated his career to health services advocacy and organisational innovation.

Leukaemia Foundation Chairman Dr Carrie Hillyard AM said the organisation was thrilled to have a professional of Mr Tanti’s calibre steering the Leukaemia Foundation into its 46th year and beyond.

“Chris’ career is characterised by the creation of game-changing health services, in addition to extensive experience in strategy, service delivery and operational management. Most importantly, Chris has a genuine resolve to change healthcare for the better and he is dedicated to improving lives and delivering lasting impact for the communities he works to serve,” she said.

“This combination means Chris brings the perfect skillset to head Australia’s leading blood cancer charity and the experience to drive progress to help Australians conquer their blood cancer. As a new decade begins, we look forward to Chris being an enthusiastic leader of both the Leukaemia Foundation and the broader blood cancer community.”

Mr Tanti said he was proud to take up position as a strong voice for all Australians living with blood cancer, no matter where they live or what their diagnosis.

“You only have to mention leukaemia, lymphoma or myeloma and you’ll soon come across someone who’s faced blood cancer themselves, or who knows and loves someone who’s been diagnosed. The sheer number of Australians impacted by this complex set of diseases is staggering, and sadly that number is continuing to rise at an extraordinary rate,” he said.

“While the blood cancer journey has improved for many, there is much work to do to improve this journey for all, and I am ready to join the passionate Leukaemia Foundation team and the wider blood cancer community to do that work – to fix our sights firmly on a future free from blood cancer and drive life-saving outcomes together.

“I am inspired by the Leukaemia Foundation’s vision and the critical role it plays in the lives of patients and families every day, and excited to lead an organisation that aligns with my values and energy to create positive, lasting change for vulnerable Australians.

“The Leukaemia Foundation is the only national charity dedicated to helping Australians with blood cancer and related disorders to survive and live their best life after diagnosis. We will create better access to treatment, care, support and information for every family facing blood cancer around Australia, wherever they are across the country, and by uniting with the broader blood cancer community, we will realise our shared vision of zero lives lost to blood cancer by 2035.

“Our goals are bold and ambitious, but they must be. We can’t stand idly by while blood cancer continues to take so many lives. It is time to turn the tables on blood cancer, and I am proud today to begin leading the organisation championing that change at a national level.”


News & Trends - Pharmaceuticals

Manoj Saxena - Bayer

Breaking the mold: Bayer GM on the future of pharma workplaces – Reimagining Healthcare Senior Leadership Series

Health Industry Hub | July 18, 2024 |

In the latest episode of the Reimagining Healthcare senior leadership series, Manoj Saxena, General Manager Pharmaceuticals ANZ at Bayer voiced […]

More


News & Trends - Pharmaceuticals

Matt Zeller, Country President of Novartis ANZ

Novartis Country President talks essentials in shaping the future of health policy: Reimagining Healthcare senior leadership series

Health Industry Hub | July 18, 2024 |

In this episode of the Reimagining Healthcare senior leadership series, Matt Zeller, Country President of Novartis ANZ, explores how health […]

More


Medical

First guidelines to stamp out rising scientific integrity issues in medical journals

First guidelines to stamp out rising scientific integrity issues in medical journals

Health Industry Hub | July 18, 2024 |

The number of retractions issued for scientific research articles in 2023 exceeded 10,000 – smashing annual records. To date, publishers […]

More


News & Trends - Pharmaceuticals

Gilead secures MSAC nod for CAR-T therapy

Gilead secures MSAC nod for CAR-T therapy

Health Industry Hub | July 18, 2024 |

Pharma News: Gilead Sciences welcomes the Medical Services Advisory Committee (MSAC) recommendation for public funding of Yescarta (axicabtagene ciloleucel) as […]

More


This content is copyright protected. Please subscribe to gain access.